Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Comparison of dried matrix spots and fabric phase sorptive extraction methods for quantification of highly potent analgesic activity agent (2R,4aR,7R,8aR)-4,7-dimethyl-2-(thiophen-2-yl)octahydro-2H-chromen-4-ol in rat whole blood and plasma using LC–MS/MS. / Lastovka, Anastasiya V.; Rogachev, Artem D.; Il'ina, Irina V. и др.
в: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Том 1132, 121813, 15.11.2019.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Comparison of dried matrix spots and fabric phase sorptive extraction methods for quantification of highly potent analgesic activity agent (2R,4aR,7R,8aR)-4,7-dimethyl-2-(thiophen-2-yl)octahydro-2H-chromen-4-ol in rat whole blood and plasma using LC–MS/MS
AU - Lastovka, Anastasiya V.
AU - Rogachev, Artem D.
AU - Il'ina, Irina V.
AU - Kabir, Abuzar
AU - Volcho, Konstantin P.
AU - Fadeeva, Valentina P.
AU - Pokrovsky, Andrey G.
AU - Furton, Kenneth G.
AU - Salakhutdinov, Nariman F.
N1 - Copyright © 2019 Elsevier B.V. All rights reserved.
PY - 2019/11/15
Y1 - 2019/11/15
N2 - The methods for quantification of highly potent analgesic agent (2R,4aR,7R,8aR)-4,7-dimethyl-2-(thiophen-2-yl)octahydro-2H-chromen-4-ol in rat whole blood and plasma were developed and validated using dried matrix spots (DMS) or fabric phase sorptive extraction (FPSE) techniques in combination with LC–MS/MS. 2-Adamantylamine hydrochloride was used as an internal standard (IS). Chromatographic separation was carried out on a reversed-phase column (2.0×75 mm, 5 μm) using water containing 0.1% formic acid and methanol containing 0.1% formic acid as mobile phases in gradient mode at a flow rate of 200 μL/min. The mass spectrometric detection was performed using electrospray ionization (ESI) in positive ion mode. MRM transitions were m/z 284.5 → 137.2/157.4 for the analgesic agent and m/z 152.3 → 93.1/107.2 for IS. Calibration curves were linear within 20–5000 ng/mL in dried plasma spots (DPS) or dried blood spots (DBS) experiments. The linearity was obtained in the range of 20–5000 ng/mL and 50–5000 ng/mL for plasma-FPSE and blood-FPSE experiments, respectively. The intra- and inter-day accuracy and precision did not exceed acceptable limits. The mean extraction recovery (%) was 26 for DPS, 25 for DBS, 38 for plasma-FPSE, 31 for blood-FPSE.
AB - The methods for quantification of highly potent analgesic agent (2R,4aR,7R,8aR)-4,7-dimethyl-2-(thiophen-2-yl)octahydro-2H-chromen-4-ol in rat whole blood and plasma were developed and validated using dried matrix spots (DMS) or fabric phase sorptive extraction (FPSE) techniques in combination with LC–MS/MS. 2-Adamantylamine hydrochloride was used as an internal standard (IS). Chromatographic separation was carried out on a reversed-phase column (2.0×75 mm, 5 μm) using water containing 0.1% formic acid and methanol containing 0.1% formic acid as mobile phases in gradient mode at a flow rate of 200 μL/min. The mass spectrometric detection was performed using electrospray ionization (ESI) in positive ion mode. MRM transitions were m/z 284.5 → 137.2/157.4 for the analgesic agent and m/z 152.3 → 93.1/107.2 for IS. Calibration curves were linear within 20–5000 ng/mL in dried plasma spots (DPS) or dried blood spots (DBS) experiments. The linearity was obtained in the range of 20–5000 ng/mL and 50–5000 ng/mL for plasma-FPSE and blood-FPSE experiments, respectively. The intra- and inter-day accuracy and precision did not exceed acceptable limits. The mean extraction recovery (%) was 26 for DPS, 25 for DBS, 38 for plasma-FPSE, 31 for blood-FPSE.
KW - (2R,4aR,7R,8aR)-4,7-dimethyl-2-(thiophen-2-yl)octahydro-2H-chromen-4-ol
KW - Analgesic agent
KW - Dried matrix spots
KW - Fabric phase sorptive extraction
KW - FPSE biofluid sampler
KW - LC–MS/MS
KW - METABOLITES
KW - ASSAY
KW - RAPID-DETERMINATION
KW - LIQUID
KW - VALIDATION
KW - ARRAY DETECTION METHOD
KW - MASS-SPECTROMETRY
KW - LC-MS/MS
KW - DRUGS
KW - AFATINIB
UR - http://www.scopus.com/inward/record.url?scp=85074443097&partnerID=8YFLogxK
U2 - 10.1016/j.jchromb.2019.121813
DO - 10.1016/j.jchromb.2019.121813
M3 - Article
C2 - 31706184
AN - SCOPUS:85074443097
VL - 1132
JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
SN - 1570-0232
M1 - 121813
ER -
ID: 22078355